174 related articles for article (PubMed ID: 6213283)
21. Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?
Sterpetti AV; Schultz RD; Feldhaus RJ; Peetz DJ
J Vasc Surg; 1985 Nov; 2(6):907-12. PubMed ID: 3877178
[TBL] [Abstract][Full Text] [Related]
22. Femoropopliteal composite dacron and autogenous vein bypass grafts. A preliminary report.
Linton RR; Wirthlin LS
Arch Surg; 1973 Nov; 107(5):748-53. PubMed ID: 4270358
[No Abstract] [Full Text] [Related]
23. Experimental evaluation of small diameter synthetic arterial grafts.
Pärsson H; Jönsson BA; Norgren L; Strand SE; Thörne J
Int Angiol; 1988; 7(1):60-4. PubMed ID: 2968426
[TBL] [Abstract][Full Text] [Related]
24. The Debatable Choice of Iliac Inflow Source for Redo Femoropopliteal and Infrapopliteal Bypass.
Gabrielli R; Ciocca F; Dante A; Musilli A; Maiorano M; Ventura M
Ann Vasc Surg; 2018 Oct; 52():316.e15-316.e19. PubMed ID: 29886210
[TBL] [Abstract][Full Text] [Related]
25. Thrombogenicity and long-term patency in autologous vein, polytetrafluoroethylene (PTFE) and silk grafts in a sheep model: evaluated through the use of indium-III-labeled platelets.
Christenson JT; Owunwanne A; Nazzal M
Am J Physiol Imaging; 1990; 5(2):80-3. PubMed ID: 2252608
[TBL] [Abstract][Full Text] [Related]
26. Sparks mandril, velour Dacron and autogenous saphenous vein grafts in femoropopliteal bypass.
Christenson JT; Eklöf B
Br J Surg; 1979 Jul; 66(7):514-7. PubMed ID: 157181
[TBL] [Abstract][Full Text] [Related]
27. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial.
Post S; Kraus T; Müller-Reinartz U; Weiss C; Kortmann H; Quentmeier A; Winkler M; Husfeldt KJ; Allenberg JR
Eur J Vasc Endovasc Surg; 2001 Sep; 22(3):226-31. PubMed ID: 11506515
[TBL] [Abstract][Full Text] [Related]
28. Relationship between the diameter of the vein graft and postoperative ankle brachial pressure index following femoro-popliteal bypass.
Matsushita M; Ikezawa T; Banno H
Int Angiol; 2008 Aug; 27(4):329-32. PubMed ID: 18677296
[TBL] [Abstract][Full Text] [Related]
29. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
[TBL] [Abstract][Full Text] [Related]
30. The salvage of the lower limbs: choice of the prosthetic material in femoro-distal and axillo-femoral bypass.
Gossetti B; Irace L; Intrieri F; Gattuso R; Aracu A; Massa R; Ciocca F; Benedetti-Valentin F
Ital J Surg Sci; 1988; 18(1):69-73. PubMed ID: 2967263
[TBL] [Abstract][Full Text] [Related]
31. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
32. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts.
Jackson MR; Belott TP; Dickason T; Kaiser WJ; Modrall JG; Valentine RJ; Clagett GP
J Vasc Surg; 2000 Sep; 32(3):498-504; 504-5. PubMed ID: 10957656
[TBL] [Abstract][Full Text] [Related]
33. Major amputations after femoropopliteal bypass procedures.
Schlenker JD; Wolkoff JS
Am J Surg; 1975 May; 129(5):495-9. PubMed ID: 124137
[No Abstract] [Full Text] [Related]
34. Polytetrafluoroethylene graft aneurysms: a report of five aneurysms.
Mohr LL; Smith LL
Arch Surg; 1980 Dec; 115(12):1467-70. PubMed ID: 7447690
[TBL] [Abstract][Full Text] [Related]
35. Sequential femoropopliteal and femorotibial bypasses. A ten-year follow-up study.
Rosenfeld JC; Savarese RP; Friedmann P; DeLaurentis DA
Arch Surg; 1981 Dec; 116(12):1538-43. PubMed ID: 6459069
[TBL] [Abstract][Full Text] [Related]
36. Platelet deposition on vascular grafts. The accuracy of in vivo quantitation and the significance of in vivo platelet reactivity.
Allen BT; Mathias CJ; Sicard GA; Welch MJ; Clark RE
Ann Surg; 1986 Mar; 203(3):318-28. PubMed ID: 2937375
[TBL] [Abstract][Full Text] [Related]
37. Preincubation of Dacron grafts with recombinant tissue factor pathway inhibitor decreases their thrombogenicity in vivo.
Rubin BG; Toursarkissian B; Petrinec D; Yang LY; Eisenberg PR; Abendschein DR
J Vasc Surg; 1996 Nov; 24(5):865-70. PubMed ID: 8918335
[TBL] [Abstract][Full Text] [Related]
38. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
39. Degenerative changes in Dacron external velour vascular prostheses (a report of three cases).
Koopmann MD; Brands LC
J Cardiovasc Surg (Torino); 1980; 21(2):159-62. PubMed ID: 6444951
[No Abstract] [Full Text] [Related]
40. Long-term results of femoro-popliteal/tibial bypasses with special references to re-operation in former femoro-popliteal procedures.
Raithel D
J Cardiovasc Surg (Torino); 1980; 21(5):541-6. PubMed ID: 6450214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
